Satellos Bioscience has announce that it has created, prioritized and advanced novel small molecule drug candidates into further preclinical studies for disease conditions, like Duchenne muscular dystrophy.
Continue readingSatellos Bioscience: Advancement of Compounds to Next Stage of Development